Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksNATCOPHARM
resources
NATCOPHARM
791.85+6.7 (+0.85%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Natco Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Natco Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Allotment of Equity Shares23 Oct 2026
    Announcement under Regulation 30 (LODR)-Allotment
    Outcome of the Fund-raising Committee meeting approving the allotment of 17058082 Equity shares
  2. Closure of Trading Window22 Oct 2026
    Closure of Trading Window
    Update on Trading Window Closure period
  3. General22 Oct 2026
    Intimation Of Closure Of The Issue Period Of The Rights Issue Of NATCO Pharma Limited (The 'Company')
    Intimation of closure of the Issue period of the Rights Issue of NATCO Pharma Limited (the "Company")
  4. Press Release / Media Release19 Oct 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Natco Pharma announces launch of Carboplatin Injection (generic of Paraplatin) in the U.S. market
  5. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201816 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliance Certificate under Reg.74(5) of SEBI(DP) Regulations, 2018
  6. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201113 Oct 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 12, 2026 for V C Nannapaneni
  7. Newspaper Publication7 Oct 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    News Paper Publications
  8. AGM30 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Evoting Results along with Scrutinizer Report for the 43rd Annual General Meeting held on 30/09/2026
  9. Closure of Trading Window30 Sept 2026
    Closure of Trading Window
    Closure of Trading Window
  10. AGM30 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Proceedings of the 43rd Annual General Meting
  11. Outcome without intimation28 Sept 2026
    Board Meeting Outcome for Outcome Of Fund Raising Committee Meeting Approving The Letter Of Offer For Rights Issue
    Outcome of Fund Raising Committee Meeting approving the Letter of Offer for Rights Issue
  12. Press Release / Media Release28 Sept 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release and disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
  13. Newspaper Publication26 Sept 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Record date for Rights Issue
  14. Record Date25 Sept 2026
    Intimation Of Record Date For Rights Issue
    Intimation of Record Date for Rights Issue
  15. Issue of Securities25 Sept 2026
    Announcement under Regulation 30 (LODR)-Issue of Securities
    Out come of Board Meeting
  16. Outcome of Board Meeting25 Sept 2026
    Board Meeting Outcome for Out Come Of Board Meeting
    Natco Pharma Limited has informed the Exchange that Board of Directors at its meeting held on September 25, 2026, has decided to issue equity shares on rights basis in the ratio of 2 : ....
  17. Board Meeting22 Sept 2026
    Board Meeting Intimation for Rights Issue Of Equity Shares
    Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2026 ,inter alia, to consider and approve to consider, discuss and decide ....
  18. General21 Sept 2026
    Receipt Of In-Principal Approval For Rights Issue Of Equity Shares
    Receipt of In-principal approval for Rights Issue of Equity Shares
  19. Issue of Securities9 Sept 2026
    Announcement under Regulation 30 (LODR)-Issue of Securities
    Draft letter of Offer
  20. Outcome of Board Meeting9 Sept 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Outcome of Board Meeting

Frequently Asked Questions

Where can I download the annual report of Natco Pharma Ltd.?
Annual reports of Natco Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Natco Pharma Ltd.?
Quarterly earnings results and presentations of Natco Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Natco Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Natco Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Natco Pharma Ltd.?
Investor presentations and annual day presentations of Natco Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Natco Pharma Ltd.?
Corporate announcements and regulatory filings of Natco Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Natco Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Natco Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Natco Pharma Ltd.?
The ISIN (International Securities Identification Number) of Natco Pharma Ltd. is INE987B01026. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Natco Pharma Ltd. listed?
Natco Pharma Ltd. is listed on NSE and BSE. The NSE symbol is NATCOPHARM and the BSE code is -.
Where can I find the shareholding pattern of Natco Pharma Ltd.?
The quarterly shareholding pattern of Natco Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Natco Pharma Ltd. on Sharpely?
Share price data for Natco Pharma Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.